The 8th Inflammasome Therapeutics Summit presents advances in understanding and targeting inflammasome pathways to develop effective therapeutics and achieve clinical impact.
Key Topics
Harnessing mechanism-based biomarkers to translate inflammasome activity into clinical efficacy
Refining inflammasome-driven immune modulation to enable meaningful clinical outcomes
Contextualizing inflammasome-related disease pathogenesis to unveil clinical milestones
Introducing delivery and therapeutic targeting tactics for inflammasome-focused drug innovation
Unravelling pathway biology to spotlight untouched activation routes and other disease links
Cracking the molecular mechanisms to reframe inflammasome research on novel targets
Building a future-proof indication strategy to achieve long-term clinical success
Who should Attend
Pharmaceutical researchers and scientists
Clinical development specialists
Immunologists and molecular biologists
Drug discovery professionals
Biotech company executives
Translational medicine experts
Regulatory affairs and clinical strategy professionals
